Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fischereder

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Journal of Nephrology|May 21, 2004
New immunosuppressive strategies in renal transplant recipientsMichael Fischereder, Matthias Kretzler
Transplant International : Official Journal of the European Society for Organ Transplantation|June 14, 2005
Prevalence of cancer history prior to renal transplantationMichael Fischereder, Karl-Walter Jauch
The New England Journal of Medicine|January 26, 2021
Belimumab in Lupus NephritisUlf Schönermarck, Stephan Kemmner, Michael Fischereder
The New England Journal of Medicine|May 28, 2020
Soluble Urokinase Receptor and Acute Kidney InjuryUlf Schönermarck, Yana Suttmann, Michael Fischereder
The New England Journal of Medicine|November 19, 2010
Rituximab or cyclophosphamide in ANCA-associated renal vasculitisUlf Schönermarck, Simon Rau, Michael Fischereder
Clinical Kidney Journal|April 9, 2015
Membrane and centrifugal therapeutic plasma exchange: practical difficulties in anticoagulating the extracorporeal circuitTobias Seibt, Michael Fischereder, Ulf Schönermarck
Arthritis and Rheumatism|June 26, 2012
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et alUlf Schönermarck, Simon Rau, Michael Fischereder
Clinical Therapeutics|October 4, 2005
Acute interstitial nephritis associated with moxifloxacin useMichael Argirov, Gesa Ricken, Daniel Zecher, et al.
Kidney & Blood Pressure Research|July 17, 2004
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end pointsUte Hoffmann, Bernhard Banas, Michael Fischereder, et al.
Infection|April 9, 2024
Sapovirus: an emerging pathogen in kidney transplant recipients?Michaela Rippl, Anton Burkhard-Meier, Ulf Schönermarck, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Journal of Nephrology|May 21, 2004
New immunosuppressive strategies in renal transplant recipientsMichael Fischereder, Matthias Kretzler
Transplant International : Official Journal of the European Society for Organ Transplantation|June 14, 2005
Prevalence of cancer history prior to renal transplantationMichael Fischereder, Karl-Walter Jauch
The New England Journal of Medicine|January 26, 2021
Belimumab in Lupus NephritisUlf Schönermarck, Stephan Kemmner, Michael Fischereder
The New England Journal of Medicine|May 28, 2020
Soluble Urokinase Receptor and Acute Kidney InjuryUlf Schönermarck, Yana Suttmann, Michael Fischereder
The New England Journal of Medicine|November 19, 2010
Rituximab or cyclophosphamide in ANCA-associated renal vasculitisUlf Schönermarck, Simon Rau, Michael Fischereder
Clinical Kidney Journal|April 9, 2015
Membrane and centrifugal therapeutic plasma exchange: practical difficulties in anticoagulating the extracorporeal circuitTobias Seibt, Michael Fischereder, Ulf Schönermarck
Arthritis and Rheumatism|June 26, 2012
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et alUlf Schönermarck, Simon Rau, Michael Fischereder
Clinical Therapeutics|October 4, 2005
Acute interstitial nephritis associated with moxifloxacin useMichael Argirov, Gesa Ricken, Daniel Zecher, et al.
Kidney & Blood Pressure Research|July 17, 2004
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end pointsUte Hoffmann, Bernhard Banas, Michael Fischereder, et al.
Infection|April 9, 2024
Sapovirus: an emerging pathogen in kidney transplant recipients?Michaela Rippl, Anton Burkhard-Meier, Ulf Schönermarck, et al.
Pageof 12